GARS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.050400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.940800E-01
Normal-vs-Stage2
3.176200E-01
Normal-vs-Stage3
6.360800E-01
Normal-vs-Stage4
2.490800E-01
Stage1-vs-Stage2
7.955600E-01
Stage1-vs-Stage3
7.208400E-01
Stage1-vs-Stage4
8.651800E-01
Stage2-vs-Stage3
5.695200E-01
Stage2-vs-Stage4
9.440200E-01
Stage3-vs-Stage4
6.630400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.078200E-01
Normal-vs-AfricanAmerican
3.380800E-01
Normal-vs-Asian
3.988200E-01
Caucasian-vs-AfricanAmerican
9.734800E-01
Caucasian-vs-Asian
4.351000E-01
AfricanAmerican-vs-Asian
5.228600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.918000E-01
Normal-vs-Female
3.129400E-01
Male-vs-Female
1.619580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.974400E-01
Normal-vs-Age(41-60Yrs)
1.315840E-01
Normal-vs-Age(61-80Yrs)
4.109000E-01
Normal-vs-Age(81-100Yrs)
3.616600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.226600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.388200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.155200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.344200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.533800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.340200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.042600E-01
Normal-vs-Daily Drinker
4.148000E-01
Normal-vs-Weekly Drinker
3.175200E-01
Normal-vs-Occasional Drinker
1.958230E-01
Normal-vs-Social Drinker
3.289800E-01
Non Drinker-vs-Daily Drinker
6.878800E-01
Non Drinker-vs-Weekly Drinker
2.012000E-01
Non Drinker-vs-Occasional Drinker
7.449500E-02
Non Drinker-vs-Social Drinker
2.025800E-01
Daily Drinker-vs-Weekly Drinker
1.712160E-01
Daily Drinker-vs-Occasional Drinker
4.202300E-02
Daily Drinker-vs-Social Drinker
1.357780E-01
Weekly Drinker-vs-Occasional Drinker
8.088400E-01
Weekly Drinker-vs-Social Drinker
7.982400E-01
Occasional Drinker-vs-Social Drinker
9.437800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.479800E-01
Normal-vs-Grade 2
8.545000E-01
Normal-vs-Grade 3
8.890200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.098800E-01
Grade 1-vs-Grade 3
5.517400E-01
Grade 1-vs-Grade 4
8.479800E-01
Grade 2-vs-Grade 3
4.341600E-01
Grade 2-vs-Grade 4
8.545000E-01
Grade 3-vs-Grade 4
8.890200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.241000E-01
Normal-vs-NonDiabetic
2.829200E-01
Diabetic-vs-NonDiabetic
8.928000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.233800E-01
Normal-vs-NoPancreatitis
2.929200E-01
Pancreatitis-vs-NoPancreatitis
7.664600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.367400E-01
Normal-vs-N1
3.316000E-01
N0-vs-N1
8.461200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.779040E-01
Normal-vs-TP53-NonMutant
4.822200E-01
TP53-Mutant-vs-TP53-NonMutant
1.287390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
